EMAIL THIS PAGE TO A FRIEND

Bio-medical materials and engineering

Synthesis and characterization of an injectable hyaluronic acid-polyaspartylhydrazide hydrogel.


PMID 28234243

Abstract

The hydrogel produced by the reaction between a hyaluronic acid derivative (HAALD) and α,β-polyaspartylhydrazide (PAHy) hydrogel was used for lacrimal duct studies. In order to improve the mechanical properties of HAALD-PAHy hydrogel, glutaraldehyde (GA) was used as a candidate to increase the mechanical properties of the hydrogel. The optimum mass ratio of the GA and PAHy was 1:50. HAALD-PAHy and HAALD-PAHy-GA50 were both synthesized in PBSA solution and characterized by different methods including gel content and swelling, rheological analysis, in vitro degradation and in vivo degradation via rheological analysis. The storage modulus (G') of the HAALD-PAHy-GA50 hydrogel reached 3800 Pa, i.e. (2.9±0.3 times higher than for HAALD-PAHy). The in vitro cytotoxicity test revealed that HAALD-PAHy-GA50 have a good biocompatibility and in vivo animal testing concluded that HAALD-PAHy-GA50 remains in the rabbit's lacrimal duct for 28 days.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

B5920
6-Benzylaminopurine hydrochloride, plant cell culture tested, ≥98%
C12H11N5 · HCl